Spontaneous tumorigenicity of primary human oral keratinocytes with human papillomavirus negativity and impaired apoptosis

International Journal of Oncology

Volumn 36, Issue 6, 2010, Pages 1491-1501

  Jang, Da Hyun ^a   Oh, Ju Eun ^a   Kang, Hyun Ki ^a   Kim, O Bok ^a   Min, Seung Ki ^a   Jung, Sung Youn ^a   Hong, Seong Doo ^a   Lee, Jae Il ^a   Min, Byung Moo ^a  

^a School of Dentistry   (South Korea)

Author keywords

Apoptosis; Chromosomal alteration; p53 mutation; Primary human oral keratinocytes; Spontaneous transformation

Indexed keywords

CISPLATIN; PROTEIN P53;

ANEUPLOIDY; ANIMAL EXPERIMENT; ANIMAL MODEL; APOPTOSIS; ARTICLE; CANCER RISK; CARCINOGENESIS; CARCINOGENICITY; CELL IMMORTALIZATION; CONTROLLED STUDY; GENE MUTATION; GENE OVEREXPRESSION; GINGIVA; KARYOTYPING; KERATINOCYTE; MARKER CHROMOSOME; MOUSE; MOUTH CARCINOMA; NONHUMAN; PHENOTYPE; PRIORITY JOURNAL; WART VIRUS;

ADULT; ANIMALS; APOPTOSIS; BLOTTING, WESTERN; CELL LINE; CELL SEPARATION; CELL TRANSFORMATION, NEOPLASTIC; CYCLIN-DEPENDENT KINASE INHIBITOR P21; FLOW CYTOMETRY; GINGIVA; HUMANS; IMMUNOHISTOCHEMISTRY; KERATINOCYTES; MICE; MICE, NUDE; MOUTH MUCOSA; MOUTH NEOPLASMS; PAPILLOMAVIRIDAE; RETINOBLASTOMA PROTEIN; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; TUMOR SUPPRESSOR PROTEIN P53; XENOGRAFT MODEL ANTITUMOR ASSAYS;

EID: 77951584092     PISSN: 10196439     EISSN: 17912423     Source Type: Journal    
DOI: 10.3892/ijo_00000636     Document Type: Article

References (39)

1. Parkin D, Bray F, Ferlay J and Pisani P: Global cancer statistics. CA Cancer J Clin 55: 74-108, 2005.
2. McDowell JD: An overview of epidemiology and common risk factors for oral squamous cell carcinoma. Otolaryngol Clin N Am 39: 229-402, 2006.
3. Forastiere A, Koch W, Trotti A and Sidransky D: Head and neck cancer. N Engl J Med 345: 1890-1900, 2001.
4. Regezi JA and Sciubba J: Ulcerative conditions. In: Oral Pathology: Clinical-Pathologic Correlations. Regezi JA and Sciubba J (eds). W.B. Saunders, Philadelphia, pp77-90, 1993.
5. Mizobuchi S, Furihata M, Sonobe H, Ohtsuki Y, Ishikawa T, Murakami H, Kurabayashi A, Ogoshi S and Sasaguri S: Association between p53 immunostaining and cigarette smoking in squamous cell carcinoma of the esophagus. Jpn J Clin Oncol 30: 423-428, 2000.
6. Gensier HL, Hall JD and Bernstein H: The DNA damage hypothesis of aging: importance of oxidative damage. In: Review of Biological Research in Aging. Rothstein M (ed). Alan R. Liss, New York, pp451-465, 1987.
7. Park N-H, Min B-M, Li S-L, Huang MZ, Cherrick HM and Doniger J: Immortalization of normal human oral keratinocytes with type 16 human papillomavirus. Carcinogenesis 12: 1627-1631, 1991.
8. Min B-M, Woo KM, Baek J-H, Lee G and Park N-H: Malignant transformation of HPV-immortalized human oral keratinocytes by chemical carcinogen. Int J Oncol 7: 249-256, 1995.
9. Hayflick L and Moorhead PS: The serial cultivation of human diploid cell strains. Exp Cell Res 25: 585-621, 1961.
10. Min B-M, Woo KM, Lee G and Park N-H: Terminal differentiation of normal human oral keratinocytes is associated with enhanced cellular TGF-β and phospholipase C-γ1 levels and apoptotic cell death. Exp Cell Res 249: 377-385, 1999. (Pubitemid 29397945)
11. Kang MK, Guo W and Park N-H: Replicative senescence of normal human oral keratinocytes is associated with the loss of telomerase activity without shortening of telomeres. Cell Growth Differ 9: 85-95, 1998. (Pubitemid 28049531)
12. Maruoka Y, Harada H, Mitsuyasu T, Seta Y, Kurokawa H, Kajiyama M and Toyoshima K: Keratinocytes become terminally differentiated in a process involving programmed cell death. Biochem Biophys Res Commun 238: 886-890, 1997. (Pubitemid 27472671)
13. Sanford KK and Evans VJ: A quest for the mechanism of 'spontaneous' malignant transformation in culture with associated advances in culture technology. J Natl Cancer Inst 68: 895-913, 1982.
14. DiPaolo JA: Relative difficulties in transforming human and animal cells in vitro. J Natl Cancer Inst 70: 3-8, 1983.
15. Barrett JC and Tennant RW: Mammalian cell transformation: mechanisms of carcinogenesis and assays for carcinogens. In: Carcinogenesis: A Comprehensive Survey. Barrett JC and Tennant RW (eds). Raven Press, New York, pp90-117, 1985.
16. Sager R, Tanaka K, Lau CC, Ebina Y and Anisowicz A: Resistance of human cells to tumorigenesis induced by cloned transforming genes. Proc Natl Acad Sci USA 80: 7601-7605, 1983. (Pubitemid 14177612)
17. Kano Y and Little JB: Mechanisms of human cell neoplastic transformation: X-ray induced abnormal clone formation in long-term cultures of human diploid fibroblasts. Cancer Res 45: 2550-2555, 1985. (Pubitemid 15024423)
18. Shin K-H, Min B-M, Cherrick HM and Park N-H: Combined effects of human papillomavirus-18 and N-Methyl-N'-nitro-Nnitrosoguanidine on the transformation of normal human oral keratinocytes. Mol Carcinog 9: 76-86, 1994.
19. Kubo C, Tsutsui TW, Tamura Y, Kumakura S and Tsutsui T: Immortalization of normal human gingival keratinocytes and cytological and cytogenetic characterization of the cells. Odontology 97: 18-31, 2009.
20. Lee KM, Choi KH and Ouellette MM: Use of exogenous hTERT to immortalize primary human cells. Cytotechnology 45: 33-38, 2004.
21. Boukamp P, Petrussevska RT, Breitkreutz D, Hornung J, Markham A and Fusenig NE: Normal keratinization in a spontaneously immortalized aneuploid human keratinocyte cell line. J Cell Biol 106: 761-771, 1988. (Pubitemid 18089976)
22. Allen-Hoffmann B L, Schlosser SJ, Ivarie CAR, Sattler CA, Meisner LF and O'Connor SL: Normal growth and differentiation in a spontaneously immortalized near-diploid human keratinocyte cell line, NIKS. J Invest Dermatol 114: 444-455, 2000. (Pubitemid 30415329)
23. Rea MA, Zhou L, Qin Q, Barrandon Y, Easley KW, Gungner SF, Phillips MA, Holland WS, Gumerlock PH, Rocke DM and Rice RH: Spontaneous immortalization of human epidermal cells with naturally elevated telomerase. J Invest Dermatol 126: 2507-2515, 2006. (Pubitemid 44582272)
24. Oh J-E, Kook J-K and Min B-M: βig-h3 induces keratinocyte differentiation via modulation of involucrin and transglutaminase expression through the integrin α3β1 and the phosphatidylinositol 3-kinase/Akt signaling pathway. J Biol Chem 280: 21629-21637, 2005.
25. Olshan AF, Weissler MC, Pei H, Conway K, Anderson S, Fried DB and Yarbrough WG: Alterations of the p16 gene in head and neck cancer: frequency and association with p53, PRAD-1 and HPV. Oncogene 14: 811-818, 1997. (Pubitemid 27100025)
26. Ansari-Lari MA, Staebler A, Zaino RJ, Shah KV and Ronnett BM: Distinction of endocervical and endometrial adenocarcinomas: immunohistochemical p16 expression correlated with human papillomavirus (HPV) DNA detection. Am J Surg Pathol 28: 160-167, 2004. (Pubitemid 38124723)
27. Slebos RJC, Yi Y, Ely K, Carter J, Evjen A, Zhang X, Shyr Y, Murphy BM, Cmelak AJ, Burkey BB, Netterville JL, Levy S, Yarbrough WG and Chung CH: Gene expression differences associated with human papillomavirus status in head and neck squamous cell carcinoma. Clin Cancer Res 12: 701-709, 2006. (Pubitemid 43259848)
28. INK4A immunohistochemical overexpression in premalignant and malignant oral lesions infected with human papillomavirus. J Histochem Cytochem 51: 1291-1297, 2003.
29. Ries JC, Schreiner D, Steininger H and Girod SC: p53 mutation and detection of p53 protein expression in oral leukoplakia and oral squamous cell carcinoma. Anticancer Res 18: 2031-2036, 1998. (Pubitemid 28344867)
30. van Heerden WF, van Rensburg EJ, Hemmer J, Raubenheimer EJ and Engelbrecht S: Correlation between p53 gene mutation, p53 protein labeling and PCNA expression in oral squamous cell carcinomas. Anticancer Res 18: 237-240, 1998. (Pubitemid 28174712)
31. Min B-M, Baek J-H, Shin K-H, Gujuluva CN, Cherrick HM and Park N-H: Inactivation of the p53 gene by either mutation or HPV infection is extremely frequent in human oral squamous cell carcinoma cell lines. Eur J Cancer B Oral Oncol 30B: 338-345, 1994.
32. Lane DP: On the expression of the p53 protein in human cancer. Mol Biol Rep 19: 23-29, 1994. (Pubitemid 2046926)
33. El-Deiry WS, Tokino T, Velculescu VE, Levy DB, Parsons R, Trent JM, Lin D, Mercer WE, Kinzler KW and Vogelstein B: WAF1, a potential mediator of p53 tumor suppression. Cell 75: 817-825, 1993. (Pubitemid 23346378)
34. Cory S, Huang David CS and Adams JM: The Bcl-2 family: roles in cell survival and oncogenesis. Oncogene 22: 8590-8607, 2002. (Pubitemid 38028528)
35. Kops GJ, Weaver BA and Cleveland DW: On the road to cancer: aneuploidy and the mitotic checkpoint. Nat Rev Cancer 5: 773-785, 2005. (Pubitemid 41400777)
36. Vogelstein B and Kinzler KW: p53 function and dysfunction. Cell 70: 523-526, 1992.
37. Harper JW, Adami GR, Wei N, Keyomarsi K and Elledge SJ: The p21 Cdk-interacting protein Cip1 is a potent inhibitor of G1 cyclin-dependent kinases. Cell 75: 805-816, 1993. (Pubitemid 23346377)
38. Reed JC: Dysregulation of apoptosis in cancer. J Clin Oncol 17: 2941-2953, 1999.
39. Sun XM, MacFarlane M, Zhuang J, Wolf BB, Green DR and Cohen GM: Distinct caspase cascades are initiated in receptor-mediated and chemical-induced apoptosis. J Biol Chem 274: 5053-5060, 1999. (Pubitemid 129501525)